Dr Reddy’s To Conduct Phase-3 Trials Of Russian Covid Vaccine Sputnik V In India

Dr Reddy’s to conduct phase-3 trials of Russian COVID vaccine Sputnik V in India

The Pharma company has reportedly asked permission from the Drugs Controller General of India.

 Dr Reddy’s To Conduct Phase-3 Trials Of Russian Covid Vaccine Sputnik V In-TeluguStop.com

One of the leading Pharma companies in India, Dr Reddy’s has asked DCGI to conduct phase-3 human clinical trials of Sputnik V in India on Friday.

According to the officials, the Russian Direct Investment Fund (RDIF) will supply 100 M doses of Sputnik to Dr Reddy’s upon the approval.

According to the source, Drugs Controller General of India is currently evaluating the technical aspects of the application, and soon a decision comes on the approval.

It is known news that the Hyderabad-based pharma company has associated with RDIF to conduct clinical trials of Sputnik V and also for its distribution.

The Sputnik V vaccine has combinedly developed by Gamaleya National Research Centre of Epidemiology and Microbiology and RDIF in Russia.

Reportedly, the officials are conducting the phase-3 trials of the vaccine in Russia since September 1.Coming to Indian vaccines, Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been conducting their phase 2 of human clinical trials.

Of all the three, sources say, Sputnik V is said to be more effective as the clinical trials demonstrated that 100% of volunteers developed immunity in just 21 days.

Follow Us on FacebookFollow Us on WhatsAppFollow Us on Twitter